Health ❯Healthcare

Pharmaceuticals

Drug Development Drug Approval Drug Pricing Drug Safety Weight Loss Drugs Clinical Trials Weight Loss Drug Regulation Obesity Treatment Cancer Treatment

WHO Recommends Six-Monthly Lenacapavir Injection for HIV Prevention

Trials demonstrating near-perfect efficacy have paved the way for a six-monthly PrEP injection under new voluntary licensing in 120 countries.

Stories older than 24h

AstraZeneca’s Baxdrostat Delivers Significant Blood Pressure Reductions in Phase 3 Trial for Resistant Hypertension

Weekly Parkinson’s Injection Secures Patent After Successful Lab Trials

FDA Publishes Over 200 Complete Response Letters for 2020–24 Drug Applications

Varda Space Industries Secures $187 Million Series C to Scale Orbital Drug Manufacturing

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy

Hims & Hers Plans Canadian Launch of Generic Semaglutide After Zava Acquisition

ProKidney Shares Climb Over 700% Ahead of FDA Meeting

Swissmedic Approves First Malaria Treatment for Newborns Under 4.5 kg

UK Regulator Probes Pancreatitis Cases Tied to GLP-1 Weight-Loss Therapies

FDA Restricts Moderna and Novavax COVID-19 Vaccines to Seniors and Vulnerable Groups

House Judiciary Committee Subpoenas Pfizer Scientist Over 2020 Vaccine Timing Allegations

FDA Clears MT-125 for First Human Trials in Treatment-Resistant Glioblastoma

Ambroxol Demonstrates Safety and Neuroprotection Signals in Parkinson’s Dementia Trial

Study Finds One in Six Cancer Medications in Sub-Saharan Africa Defective

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

FDA Approves Six-Month HIV Prevention Injection Lenacapavir

Novo Nordisk Launches Wegovy Weight-Loss Drug in India

Zimislecel Therapy Enters Phase 3 After Majority of Type 1 Diabetes Patients Go Insulin-Free

Experimental Drug SANA Boosts Fat Thermogenesis to Promote Weight Loss Ahead of Phase 2 Trials